Composition for ophthalmic disease associated with hypoxia...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/426 (2006.01) A61P 9/00 (2006.01) A61P 27/02 (2006.01)

Patent

CA 2691520

According to the present invention, a composition containing a VAP-1 inhibitor as an active ingredient, which is effective for ophthalmic diseases associated with hypoxia or ischemia can be provided. According to the present invention, moreover, an angiogenesis inhibitor that suppresses pathologic angiogenesis associated with hypoxia or ischemia can be provided.

L'invention concerne une composition efficace pour une maladie ophtalmique associée à une hypoxie ou une ischémie, qui comprend un inhibiteur VAP-1 en tant qu'ingrédient actif. Un inhibiteur d'angiogenèse qui peut empêcher une angiogenèse morbide associée à une hypoxie ou une ischémie est également décrit.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Composition for ophthalmic disease associated with hypoxia... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Composition for ophthalmic disease associated with hypoxia..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Composition for ophthalmic disease associated with hypoxia... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1561186

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.